Foster Dykema Cabot & Partners, LLC Eli Lilly & CO Transaction History
Foster Dykema Cabot & Partners, LLC
- $1.12 Trillion
- Q2 2024
A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 43,739 shares of LLY stock, worth $41.6 Million. This represents 3.54% of its overall portfolio holdings.
Number of Shares
43,739
Previous 43,951
0.48%
Holding current value
$41.6 Million
Previous $34.2 Billion
15.82%
% of portfolio
3.54%
Previous 3.18%
Shares
3 transactions
Others Institutions Holding LLY
# of Institutions
3,857Shares Held
751MCall Options Held
6.34MPut Options Held
7.97M-
Lilly Endowment Inc Indianapolis, IN97.4MShares$92.5 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.9MShares$70.2 Billion1.31% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$62.6 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$48.8 Billion31.1% of portfolio
-
State Street Corp Boston, MA33.9MShares$32.2 Billion1.36% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $903B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...